Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 5, 2002, Pages 1284-1290

  Hong, Ji Hong ^a,b   Tsai, Chien Sheng ^a   Lai, Chyong Huey ^c   Chang, Ting Chang ^c   Wang, Chun Chieh ^a   Lee, Steve P ^d   Tseng, Chih Jen ^c   Hsueh, Swei ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Early stage cervical cancer; Gastrointestinal complications; Low pelvic irradiation; Lymphedema; Postoperative radiotherapy

Indexed keywords

CELLS; HISTOLOGY; IRRADIATION; PATHOLOGY; PATIENT MONITORING; TUMORS;

MULTIVARIATE ANALYSIS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LEG EDEMA; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SMALL INTESTINE DISEASE; STROMA; SURVIVAL RATE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; VASCULAR DISEASE;

ADULT; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0036680557     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02831-6     Document Type: Article

References (23)

1. Parametrial involvement, regardless of nodal status: A poor prognostic factor for cervical cancer
2. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: An analysis of 891 cases
3. Are adenocarcinomas and adenosquamous carcinomas different from squamous carcinomas in stage IB and II cervical cancer patients undergoing primary radical surgery?
4. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study
5. Stage IB and IIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy
6. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial
7. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer
8. Adjuvant radiotherapy after radical hysterectomy of the cervical cancer: Prognostic factors and complications
9. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection: A pilot study
10. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy
11. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
12. Uterine cervix
13. Overview
14. A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix
15. Recurrent cervical carcinoma after primary radical surgery
16. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996)
17. Small bowel obstruction following radical hysterectomy: Risk factors, incidence, and operative findings
18. The use of a pelvic displacement prosthesis to exclude the small intestine from the radiation field following radical hysterectomy
19. Three-dimensional treatment planning for postoperative radiotherapy in patients with node-positive cervical cancer: Comparison between a conventional and a conformal technique
20. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix
21. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
22. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
23. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer